Trends in liver transplantation 2011 (Q37980892)

26 August 2017

title

Trends in liver transplantation 2011 (English)

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

24 December 2024

main subject

liver transplantation

1 reference

1

Patrizia Burra

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22300460

24 December 2024

2

Richard Freeman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22300460

24 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22300460

24 December 2024

publication date

1 January 2012

1 reference

26 August 2017

2012

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22300460

full work available at URL

24 December 2024

https://api.elsevier.com/content/article/PII:S0168827812600117?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

https://api.elsevier.com/content/article/PII:S0168827812600117?httpAccept=text/plain

24 December 2024

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

24 December 2024

published in

Journal of Hepatology

1 reference

26 August 2017

volume

56 Suppl 1

1 reference

26 August 2017

page(s)

S101-11

1 reference

Short- and long-term donor morbidity in right lobe living donor liver transplantation: 91 consecutive cases in a European Center

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Donor morbidity after living donation for liver transplantation

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Adult right-lobe living liver donors: quality of life, attitudes and predictors of donor outcomes

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Transplantation risks and the real world: what does 'high risk' really mean?

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Laparoscopy-assisted and open living donor right hepatectomy: a comparative study of outcomes

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Video-assisted living donor hemihepatectomy through a 12-cm incision for adult-to-adult liver transplantation

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Living donor liver transplantation using dual grafts from two donors: a feasible option to overcome small-for-size graft problems?

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Current and future trends in liver transplantation in Europe

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Liver transplantation: Issues for the next 20 years

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Understanding of and attitudes to organ donation and transplantation: a survey among Italian university students

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

"Rescue allocation offers" in liver transplantation: is there any reason to reject "unwanted" organs?

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Is the increase in DCD organ donors in the United Kingdom contributing to a decline in DBD donors?

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Multifactorial biological modulation of warm ischemia reperfusion injury in liver transplantation from non-heart-beating donors eliminates primary nonfunction and reduces bile salt toxicity.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Peritoneal cooling may provide improved protection for uncontrolled donors after cardiac death: an exploratory porcine study

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

One hour hypothermic oxygenated perfusion (HOPE) protects nonviable liver allografts donated after cardiac death

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Liver transplant using donors after unexpected cardiac death: novel preservation protocol and acceptance criteria

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

In-vivo normothermic recirculation: an update

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Technical refinements and results in full-right full-left splitting of the deceased donor liver

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Split-liver transplantation in the high-MELD adult patient: are we being too cautious?

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Outcomes in adult recipients of right-sided liver grafts in split-liver procedures.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Split liver transplantation: King's College Hospital experience

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Liver transplant from Anti-HBc-positive, HBsAg-negative donor into HBsAg-negative recipient: is it safe? A systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Liver grafts from anti-hepatitis B core positive donors: a systematic review

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Survival benefit-based deceased-donor liver allocation

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple model for end-stage liver disease-independent prognostic factors

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Prioritization for liver transplantation

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Selection of patients for liver transplantation and allocation of donated livers in the UK.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Height Contributes to the Gender Difference in Wait-List Mortality Under the MELD-Based Liver Allocation System

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Simultaneous liver-kidney transplantation in the MELD era.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Re-weighting the model for end-stage liver disease score components

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

The economic impact of the utilization of liver allografts with high donor risk index

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Disparities in liver transplantation before and after introduction of the MELD score

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Survival before and after model for end-stage liver disease score introduction on the Brazilian liver transplant waiting list.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Model for end-stage liver disease-based allocation system for liver transplantation in Argentina: does it work outside the United States?

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

The survival benefit of liver transplantation

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

"Survival benefit": the final destination, with still a long way to go

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the s

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Life expectancy of adult liver allograft recipients in the UK.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Liver transplantation in the United States, 1999-2008.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

1 reference

7 January 2021

Identification of cellular and viral factors related to anti-hepatitis C virus activity of cyclophilin inhibitor

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry).

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Hepatocellular carcinoma--what's new?

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Outcomes of loco-regional therapy for down-staging of hepatocellular carcinoma prior to liver transplantation

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Molecular signature for HCC: role in predicting outcomes after liver transplant and selection for potential adjuvant treatment

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Immunosuppression, cancer, and the long-term outcomes after liver transplantation: can we do better?

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Immunosuppression for liver transplantation

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Tolerance in clinical transplantation: progress, challenge or just a dream?

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Operational Tolerance After Liver Transplantation: Raising the Bar or Tripping Up?

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Long-Term Follow-Up of 23 Operational Tolerant Liver Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Documented deaths of hepatic lobe donors for living donor liver transplantation

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Living donor liver transplantation--adult donor outcomes: a systematic review

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Living liver donor mortality: where do we stand?

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Results of 132 hepatectomies for living donor liver transplantation: report of one death

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Toward current standards of donor right hepatectomy for adult-to-adult live donor liver transplantation through the experience of 200 cases

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

The first donor death after living-related liver transplantation in Japan

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Donor complications associated with living donor liver transplantation in Japan.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Fulminant and fatal gas gangrene of the stomach in a healthy live liver donor

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Liver transplantation using a right liver lobe from a living donor.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Living donor liver transplantation in adults: outcome in Europe

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Right living donor liver transplantation: an option for adult patients: single institution experience with 74 patients

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Selection of the living liver donor

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

[Selection of live donors for segmental liver transplantation in children]

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Evolution of donor morbidity in living related liver transplantation: a single-center analysis of 165 cases

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Adult living liver donors have excellent long-term medical outcomes: the University of Toronto liver transplant experience.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Surgical complications in 100 donor hepatectomies for living donor liver transplantation in a single Brazilian center.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Complications of right lobe living donor liver transplantation

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

A prospective analysis of living-liver donation shows a high rate of adverse events

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

7 January 2021

Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium

2

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

NK Cells, Innate Immunity and Hepatitis C Infection after Liver Transplantation

24 December 2024

57

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

Cost-effectiveness analysis of the Dutch liver transplantation programme

24 December 2024

73

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

Ethical dilemmas in living donor liver transplantation

24 December 2024

92

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

Analysis of right lobe living-liver donor complications: a single center experience

24 December 2024

105

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(12)60011-7

24 December 2024

Identifiers

1 reference

26 August 2017

1 reference